STAT3 and metabolic dysfunction-associated steatohepatitis: Activation of STAT1 promotes T-cell recruitment, NASH, and fibrosis, but not HCC, whereas inhibition of STAT3 signaling prevented HCC without affecting NASH and fibrosis,427 suggesting the possibility of separative treatment of NASH and HCC.